Lyme disease: What’s actually going on here?
I am a microbiologist that has done 25+ years of work on Borreliosis and the effects of Borrelia infection of the human brain.
The only reason there is a controversy about the persistence of LIVE Borrelia spirochetes in patients that have been treated with antibiotics is simply that the CDC, NIH, Yale, Mayo Clinic, and SUNY all have patents on blood-tests for Lyme disease, and base their conclusions on blood tests. This is not only a financial conflict of interest, but now is a problem with reputations and jobs. ConflictReport
The most notable Lyme disease experts have not done a single brain autopsy to confirm the absence of infection. Not one tax-payer dollar has been spent on brain pathology to investigate Borrelia species in dementia, MS, or chronic Lyme disease or neuro Borrelia myamotoi.
Several private funded pathologists have done the research and found persistence and some interesting pathology.
Borrelia can persist behind the blood-brain-barrier for decades. Further, the spirochete can take refuge inside human brain-neurons. No blood test can detect this type of persistence, because the peripheral immune system stops detecting the infection.
To make things more difficult both Borrelia burgdorferi and Borrelia myamotoi form clusters surrounded by secreted glycoprotein gel and embeds inside amyloid plaques.
This is low hanging fruit waiting to be picked by the CDC or State Health Departments, but they refuse to do the brain pathology needed, even though many brain-banks offer ample easy access and samples they haven’t and won’t spend a dime that would ruin the reputations of the serology-cartel.
Attached are just a few of hundreds of images showing persistence despite negative blood tests.
1. B. myamotoi in Alzheimer’s plaque.jpeg
2. Borrelia Pathology Poster br.pdf
3. Forris Intra Bb.jpeg
4. InternalBb Neuron Mac.jpeg
5. livengoode neuron.jpeg
6. Screen Shot 2019-07-03 at 8.45.05 PM.png
7. Screen Shot 2019-07-03 at 8.45.16 PM.png
End of letter
About Tom Grier:
HS 85 – Bad Science and Lyme Disease with Tom Grier
“Thomas Grier M.S. studied Clinical Immunology and Microbiology at the University of MN Duluth, and began a doctorate program in Geriatrics until the program was discontinued. He then worked on human vaccine development and developed antibody testing to detect bacteria in Pylonephritis. He also worked on a T-cell model of Leukemia in mice trying to target the immune system against Leukemia-Lymphocytic markers to reduce Lymphocyte levels. In 1990, he was misdiagnosed with MS and was finally diagnosed with Lyme Encephalitis in 1991. Following his fight with recovering from this disease, he wrote the “Lyme Disease Survival Manual” for patients, which sold worldwide. Currently, Tom is the Executive Director of Pathology Studies at MIBDEC. MIBDEC is an non-profit organization trying to register Dementia and MS patients to donate their brains to science to look for spirochetes (Lyme) as a possible connection to some (not all) dementias. He does this because of the refusal by health departments, the NIH or CDC to do the proper work to rule out spirochetes within the brain as a cause of our increased rate of dementia in America and around the temperate latitudes of the Northern Hemisphere. Also like many in his field, he is concerned about the government not telling us the truth about epidemic diseases and the purposely funding of bad science. There are also conflicts of financial interest that prevent good science from prevailing.”